Mr. Parker is a General Partner at Ampersand Capital Partners. His investment experience has been across various healthcare sectors, including clinical diagnostics products, laboratory services, life science research products, medical devices, pharmaceutical outsourcing services and specialty pharmaceuticals. He has served on the Board of Directors of ACLARA Biosciences, Bako Pathology Services, Bioventus, Cutis Pharma, IBT Laboratories, Modified Polymer Components, NOVEX (Life Technologies), Ortho Organizers, Roadrunner Pharmacy, Signature Genomic Laboratories and Stereotaxis. Prior to joining Ampersand Capital Partners in 1994, Mr. Parker was a management consultant at Bain & Company and Mercer Management Consulting. Mr. Parker earned his B.A. in Government from Dartmouth College and an M.B.A. with a concentration in Finance from the Wharton School.
©2017 CutisPharma, Inc.
FI℞ST® and the FI℞ST® logo are registered
trademarks of CutisPharma, Inc.